• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Afobazole-[d4]

General Information
Catalog: BLP-014978
Molecular Formula: C15H17D4N3O2S
Molecular Weight: 311.44
Chemical Structure
Afobazole-[d4]
Description Afobazole-[d4] is a labelled Afobazole, which is a drug used to treat anxiety disorders with neuroprotective effects.
Synonyms 4-(2-((6-Ethoxy-1H-benzo[d]imidazol-2-yl)thio)ethyl-1,1,2,2-d4)morpholine; Afobazole-D4; Fabomotizole-d4; Afobazole-d4; Obenoxazine-d4; Afobazol-d4; Aphobazole-d4; 4-(2-((5-ethoxy-1H-benzo[d]imidazol-2-yl)thio)ethyl-d4)morpholine; 5-Ethoxy-2-((2-(morpholin-4-yl)ethyl-d4)sulfanyl)-1H-benzimidazole
IUPAC Name 4-(2-((6-ethoxy-1H-benzo[d]imidazol-2-yl)thio)ethyl-1,1,2,2-d4)morpholine
Related CAS 173352-21-1 (unlabelled)
Canonical SMILES CCOC1=CC=C2C(NC(SC([2H])([2H])C(N3CCOCC3)([2H])[2H])=N2)=C1
InChI InChI=1S/C15H21N3O2S/c1-2-20-12-3-4-13-14(11-12)17-15(16-13)21-10-7-18-5-8-19-9-6-18/h3-4,11H,2,5-10H2,1H3,(H,16,17)/i7D2,10D2
InChI Key WWNUCVSRRUDYPP-AQVLYMJBSA-N
Purity >95%
Storage Store at 2-8 °C

Interested in our Service & Products?
Need detailed information?

USA
  • International: 1-631-504-6093
  • US & Canada (Toll free): 1-844-BOC(262)-0123
  • 45-16 Ramsey Road, Shirley, NY 11967, USA
  • Email: info@bocsci.com
  • Fax: 1-631-614-7828
UK
  • 44-20-3286-1088
  • 85 Great Portland Street, London, W1W 7LT
  • Email: info@bocsci.com
Copyright © 2025 BOC Sciences. All Rights Reserved.
0
Inquiry Basket

No data available, please add!

Delete selectedGo to checkout

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x